Abstract
The merging of medication and analysis has been more widely endorsed in recent years. However, the issue of the analyst needing pharmacotherapy and how its use presses on the analytic frame has not been considered. This essay will look at how the analyst's need for medication threads into the structure of treatment. Issues of stigma and shame triggered by medication use are discussed, as well as the treatment consideration of self-disclosure as an intervention. The author offers both objective and subjective data on this subject, and includes a clinical case example to illustrate how self-disclosure of medication status can offer greater degrees of freedom in a patient's analysis.
Similar content being viewed by others
REFERENCES
Abel-Horowitz, J. (1998). Psychopharmacotherapy during an analysis. Psychoanalytic Inquiry, 18(5): 673–701.
Abend, S. M. (1982). Serious illness in the analyst: Countertransference considerations. The Journal of the American Psychoanalytic Association, 30: 365–379.
Adelman, S.A. (1985). Pills as transitional objects: A dynamic understanding of the use of medication in psychotherapy. Psychiatry, 48: 246–253.
Aron, L. (1996). A meeting of Minds: Mutuality in Psychoanalysis. New Jersey: The Analytic Press.
Barrett, M. & Berman, J. (2001). Is psychotherapy more effective when therapists disclose information about themselves? Journal of Consulting and Clinical Psychology, 4: 597–603.
Beitman, B. (1996). Integrating pharmacotherapy and psychotherapy: An emerging field of study. Bulletin of the Menninger Clinic, 60(2): 160–173.
Blechner, M.J. (1996). Psychoanalysis in and out of the closet. In: The Therapist as a Person, B. Gerson (Ed). New Jersey: The Analytic Press, pp. 223–239.
Chused J.F. & Raphling, D. (1992). The analyst's mistakes. The Journal of the American Psychoanalytic Association, 40: 89–116.
Colson, D. B. (1995). An analyst's multiple losses: Countertransference and other reactions. Contemporary Psychoanalysis, 31: 459–477.
Cookson, J. (1993). Side Effects of antidepressants. British Journal of Psychiatry, 163: 20–24.
Cristy, B. (2001). Wounded healer: The impact of a therapist's illness on the therapeutic situation. Journal of the American Academy of Psychoanalysis, 29(1): 33–42. 240 Serani
Dewald, P. (1982). Serious illness in the analyst:Transference, countertransference and reality response. The Journal of the American Psychoanalytic Association, 30: 347–364.
Donovan, S. J. & Roose, S. P. (1995). Medication use during analysis: A survey. Journal of Clinical Psychiatry, 56(5): 117–178.
Fenster, S; Phillips, S; & Rapoport, E. (1988). The Therapist's Pregnancy: Intrusion in the Analytic Space. New Jersey: The Analytic Press.
Feiner, A. (1991). The analyst's participation in the patient's transference-Presence, contact and change. Contemporary Psychoanalysis, 27: 208–240.
Finkel, J. (1986). Discussion. Contemporary Psychoanalysis. 22: 234–240.
Flapan, D. (1986). The trauma of the therapist's illness. Issues in Ego Psychology. 9(2): 32–39.
Friedman, G. (1991). Impact of a therapist's life threatening illness on the therapeutic situation. Contemporary Psychoanalysis, 27: 405–421.
Frank, K. (1999). Psychoanalytic Participation: Action, Interaction and Integration. New Jersey: The Analytic Press.
Frankel, A. (1993). Crisis in the life of the therapist. Contemporary Psychotherapy Review, 8: 77–89.
Freud, S. (1940). An outline of psychoanalysis. Standard Edition, 23: 144–207.
Gabbard, G. (1994). Mind and brain in psychiatric treatment. Bulletin of the Menninger Clinic, 58: 540–545.
Gabbard, G. (2001). Empirical Evidence and Psychotherapy: A growing scientific base. American Journal of Psychiatry, 158: 1–3.
Gerson, B. (1994). An analyst's pregnancy loss and its effects on treatment disruption and growth. Psychoanalytic Dialogues, 4(1): 1–17.
Gilverbert, F. & Simon, B. (1981). A death in the life of a therapist and its impact on therapy. Psychiatry, 44: 141–149.
Gold, J. R. (1996). Key Concepts in Psychotherapy Integration. New York: Plenum Press.
Goldberg, A. (1984). Personal observations of a therapist with life threatening illness. International Journal of Group Psychotherapy, 34: 289–296.
Goldstein, E. G. (1994). Self-disclosure in treatment: What therapists do and don't talk about. Clinical Social Work Journal, 22: 417–433.
Greenberg, J. (1995). Self-disclosure: Is it analytic? Contemporary Psychoanalysis, 31: 193–205.
Greenhill, M. & Gralnick, A. (1983). Psychopharmacology and Psychotherapy. New York: The Free Press.
Hausner, R. (1986). Medication as transitional phenomena. International Journal of Psychoanalytic Psychotherapy, 11: 375–398.
Isay, R. (1991). The homosexual analyst: Clinical considerations. Psychoanalytic Study of the Child, 46: 199–216.
Jamison, K. R. (1995). An Unquiet Mind. New York: Knopf.
Janda, L. H., England, K., Lovejoy, D., Drury, K. (1998). Attitudes toward psychology relative to other disciplines. Professional Psychology: Research and Practice, 29(2): 140–143.
Kahn, D. (1991). Medication consultation and split during psychotherapy. Journal of the American Academy of Psychoanalysis, 19(1): 84–98.
Kandel, E. R. (1999). Biology and the future of psychoanalysis: A new intellectual framework for psychiatry revisited. American Journal of Psychiatry, 156: 505–524.
Kaplan-Solms, K. & Solms, M. (2000). Clinical Studies in Neuro-Psychoanalysis. New York: International Universities Press.
Karasu, T. B. (1990). Toward a clinical model of psychotherapy for Depression: An integrative and selective treatment approach. American Journal of Psychiatry, 147: 269–278.
Kubler-Ross, E. (1970). On Death and Dying. New York: Macmillan.
Lasky, R. (1990). Catastrophic illness in the analyst and the analyst's emotional reactions to it. International Journal of Psycho-Analysis, 71(3): 455–473.
Levy, S. R. (1977). Countertransference aspects of pharmacotherapy in the treatment of schizophrenia. International Journal of Psychoanalytic Psychotherapy, 6: 15–30.
Lindner, H. (1984). Therapist and patient reactions to life threatening crisis in the therapist's life. International Journal of Clinical Experiential Hypnosis, 32: 12–27.
Lyons, M. & Ziviani, J. (1995). Stereotypes, stigma, and mental illness: Learning from fieldwork experiences. American Journal of Occupational Therapy, 49(10): 1002–1008. Analyst in the Pharmacy 241
Marmor, J. (1981). The adjunctive use of drugs in psychotherapy. Journal of Clinical Psychopharmacology, 1: 312–315.
Martin, A. (1998). Psychopharmacology update: What's new in the treatment of depression. Psychoanalysis & Psychotherapy. 15(1): 131–134.
Mendelsohn, E.M. (1996). More human than otherwise: Working though a time of preoccupation and mourning. In: The Therapist as a Person, B. Gerson (Ed). New Jersey: The Analytic Press, pp. 21–40.
Mitchell, S. (1981). Relational Concepts in Psychoanalysis: An integration. MA: Harvard University Press.
Morrison, A. (1997). Ten years of doing psychotherapy while living with a life threatening illness: Self-disclosure and other ramifications. Psychoanalytic Dialogues, 2: 115–140.
Nevins, D. B. (1990). Psychoanalytic perspectives on the use of medication for mental illness. Bulletin of the Menninger Clinic, 54(3): 323–339.
Normand, W. & Bluestone, H. (1986). The use of pharmacotherapy in psychoanalytic treatment. Contemporary Psychoanalysis, 22: 218–234.
Olds, D. & Cooper, A. (1997). Dialogue with other sciences: Opportunities for mutual gain. International Journal of Psycho-Analysis, 78: 219–225.
Ostow, M. (1960). The use of drugs to overcome technical difficulties in psychoanalysis In: The Dynamics of Psychiatric Drug Therapy Ed. G. Sarwer-Foner. Springfield: C. C. Thomas.
Ostow, M. (1992). The use of medication with patients in analysis: Panel of the New York analytic society. Journal of Clinical Psychoanalysis, 1: 57–68.
Pally, R. & Solms, M. (2000). The Mind-Brain Relationship. International Journal of Psychoanalysis Key Paper Series. London: The Other Press.
Phillips, S. (1998). A new analytic dyad: Homosexual analyst, heterosexual patient. The Journal of the American Psychoanalytic Association, 46(4): 1195–1219.
Pizer, B. (1997). When they analyst is ill: Dimensions of Self-Disclosure. Psychoanalytic Quarterly, 66: 450–469.
Renik, O. (1999). Playing one's cards face up in analysis: An approach to the problem of self-disclosure. Psychoanalytic Quarterly, 68: 521–539.
Salzman, C. (1998). Integrating pharmacotherapy and psychotherapy in the treatment of a bipolar patient. American Journal of Psychiatry, 155: 686–688.
Satcher, D. (2000). Mental health: A report of the surgeon general-Executive summary. Professional Psychology: Research and Practice, 31(1): 5–13.
Sarwer-Foner, G. (1960). The Dynamics of Drug Therapy. Springfield: C. C. Thomas.
Schlachet, P. (1996). When the therapist divorces. In: The Therapist as a Person, B. Gerson (Ed). New Jersey: The Analytic Press, pp. 141–157.
Schwartz, H. (1987). Illness in the doctor: Implications for the psychoanalytic process. Journal of American Psychoanalytic Association, 35: 657–692.
Silver, A. (1990). Resuming work with a life threatening illness: And further reflections. In: Illness in the Analyst, Eds. H.J. Schwartz & A. Silver. Connecticut: 151–176.
Smyer. M., Blaster, R., Egli, D., Kilbey, M., Leith, N. & Puente, A. (1993). Summary of the report of the ad hoc task force of psychopharmacology of the American Psychological Association. Professional Psychology: Research and Practice, 24(4): 394–403.
Valenstein, E. (1998). Blaming the Brain: The Truth About Drugs and Mental Health. New York: Free Press.
Wiggins, J. (2001). Personal communication.
Winnicott, D. W. (1969). The use of an object. International Journal of Psychoanalysis, 50: 711–716.
Wylie, H. W. & Wylie, M. L. (1987). An effect of pharmacotherapy on the psychoanalytic process: Case report of a modified analysis. American Journal of Psychiatry, 144(4): 489–492.
Wylie, H. W. & Wylie, M. L. (1996).“Bright spot”: Technical recommendations concerning a phenomenon observed when combining psychoanalysis and medication. Journal of Clinical Psychoanalysis, 5(4): 553–559.
Rights and permissions
About this article
Cite this article
Serani, D. The Analyst in the Pharmacy. Journal of Contemporary Psychotherapy 32, 229–241 (2002). https://doi.org/10.1023/A:1020501227827
Issue Date:
DOI: https://doi.org/10.1023/A:1020501227827